(EVLN) Morgan Stanley Trust - Overview
Etf: Loans, Bonds, CLOs, Mezzanine, Subordinated
Dividends
| Dividend Yield | 6.60% |
| Yield on Cost 5y | 7.56% |
| Yield CAGR 5y | 11.52% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 2.81% |
| Relative Tail Risk | -3.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.18 |
| Alpha | -0.61 |
| Character TTM | |
|---|---|
| Beta | 0.108 |
| Beta Downside | 0.135 |
| Drawdowns 3y | |
|---|---|
| Max DD | 2.78% |
| CAGR/Max DD | 2.29 |
Description: EVLN Morgan Stanley Trust January 16, 2026
The Morgan Stanley ETF Trust EVLN is a U.S.–based exchange-traded fund that targets the bank-loan space, allocating at least 80 % of its net assets to floating-rate credit instruments such as senior floating-rate loans, CLO debt tranches, and both secured and unsecured floating-rate bonds.
Key metrics (as of the most recent filing) show an expense ratio of roughly 0.45 %, a weighted-average maturity of about 4.2 years, and a current weighted-average yield near 5.1 %, reflecting the fund’s exposure to short-term, rate-sensitive credit.
Because the holdings are floating-rate, the fund’s performance is closely tied to the trajectory of short-term benchmarks (SOFR) and to credit-spread dynamics; a rising rate environment typically supports income, while widening spreads can erode returns, especially for lower-rated borrowers.
Investors should monitor macro drivers such as Federal Reserve policy, corporate debt issuance trends, and the health of the leveraged-loan market, all of which materially affect the fund’s risk-return profile.
For a deeper, data-driven look at how EVLN fits into a broader portfolio, you might explore the analytics on ValueRay.
What is the price of EVLN shares?
Over the past week, the price has changed by +0.03%, over one month by -0.31%, over three months by +0.74% and over the past year by +4.69%.
Is EVLN a buy, sell or hold?
What are the forecasts/targets for the EVLN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 54.1 | 10.4% |
EVLN Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.32b USD (1.32b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.32b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.32b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.31% (E(1.32b)/V(1.32b) * Re(6.31%) + (debt-free company))
Discount Rate = 6.31% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)